Corrigendum to “SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA/2J male mice” [Bone 82 (2016) 101–107](S8756328215002999)(10.1016/j.bone.2015.07.025)

Kathryn M. Thrailkill, R. C. Bunn, Jeffry S. Nyman, Mallikarjuna R. Rettiganti, Gael E. Cockrell, Elizabeth C. Wahl, Sasidhar Uppuganti, Charles K. Lumpkin, John L. Fowlkes

Research output: Contribution to journalComment/debate

2 Scopus citations

Abstract

The authors regret Fig. 2D is incorrect. Bars were erroneously graphed using data for standard deviation (SD) rather than the mean and were presented as SD +-SD rather than as mean + -SD. This was an error in graphing only and not in accuracy or validity of the results. The correct figure appears below. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Pages (from-to)316
Number of pages1
JournalBone
Volume105
DOIs
StatePublished - Dec 2017

Bibliographical note

Publisher Copyright:
© 2016

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Physiology
  • Histology

Fingerprint

Dive into the research topics of 'Corrigendum to “SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA/2J male mice” [Bone 82 (2016) 101–107](S8756328215002999)(10.1016/j.bone.2015.07.025)'. Together they form a unique fingerprint.

Cite this